Journals / Haseki Tıp Bülteni / 2017 / Cilt: 55 - Sayı: 2

Infrapopliteal Percutan Transluminal Angioplasty of Patients with TASC D Group Diabetic Foot Lesions According to the Transatlantic Inter-Society Consensus II

Transatlantik Toplulukları Fikir Birliği II TASC D Grubundaki Diyabetik Ayak Yarasına Sahip Olgularda Diz Altı Perkütan Transluminal Anjiyoplasti

Pages
125–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall initial technical success rate in PTA was 68.8%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:im: We aimed to evaluate the effectiveness of percutaneous transluminal angioplasty (PTA) in limb salvage in patients with diabetic foot disease and critical limb ischemia according to the Trans-Atlantic Inter-Society Consensus II (TASC) classification system for type TASC D infrapopliteal artery disease.
📊
Key Findings & Data:Methods: We retrospectively reviewed the angiographic records of patients with diabetic food disease and critical limb ischemia who underwent PTA between January 2014 and December 2015.
💡
Conclusion & Impact:The overall initial technical success rate in PTA was 68.8%.
🔬Design:Review & Systematic Survey
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

im: We aimed to evaluate the effectiveness of percutaneous transluminal angioplasty (PTA) in limb salvage in patients with diabetic foot disease and critical limb ischemia according to the Trans-Atlantic Inter-Society Consensus II (TASC) classification system for type TASC D infrapopliteal artery disease. Methods: We retrospectively reviewed the angiographic records of patients with diabetic food disease and critical limb ischemia who underwent PTA between January 2014 and December 2015. Patients with TASC D isolated infrapopliteal artery disease and followed up for 12 months were included in the study. Technical success and limb salvage rates at 12 months were evaluated. Results: During the study period, 72 patients were screened for study enrolment and 32 met the inclusion criteria. The overall initial technical success rate in PTA was 68.8%. Limb salvage rate was 72.7% at 12 months in patients who had technical success. Among the factors that affected initial technical success and limb salvage at 12 months, only length of occlusion was found to be significant. Conclusion: PTA shows an effective technical success and good limb salvage rates in di¬abetic patients with TASC D group of critical limb ischemia. PTA may be attempted as an alternative treatment in patients with critical limb ischemia rated unfit for surgery.

Özet

Amaç: Bu çalışmanın amacı Transatlantik Toplulukları Fikir Birliği II (Transatlantic İntersociety Consensus II; TASC) sınıflamasına göre TASC D grubunda olan kritik bacak iskemili, diyabetik ayak yarasına sahip olgularda diz altı arteriyel yapılara uygulanmış perkütan transluminal anjiyoplastinin (PTA) uzuv korumaya etkisini araştırmaktır. Yöntemler: Ocak 2014 - Aralık 2015 tarihleri arasında, kritik bacak iskemisi nedeniyle endovasküler revaskülarizasyon tedavisi uygulanmış diyabetik ayak yarasına sahip hastaların anjiyografik görüntüleri retrospektif olarak incelendi. Çalışmaya TASC D izole infrapopliteal arter hastalığı olan ve 12 aylık takibi bulunan hastalar dahil edildi. Bu olgulardaki işlem başarısı ve 12 aylık uzuv korunma oranları araştırıldı. Bulgular: Çalışma süresince 72 hastanın kayıtları incelendi ve çalışma kriterlerine uyan 32 olgu çalışmaya alındı. Perkütan translüminal anjiyoplasti işlemindeki teknik başarı oranı %68,8 olarak bulundu. İşlem başarılı olan hastalarda 12 ay uzuv korunma oranı %72,7 idi. İşlem başarısını ve 12 aylık uzuv korunma süresini etkileyen faktörler arasında sadece oklüzyon uzunluğu anlamlı bulundu. Sonuç: PTA, TASC D grubunda kritik bacak iskemisine sahip diyabetli olgularda etkin teknik başarı ve iyi uzuv korunma oranlarına sahiptir. Cerrahiye uygun olmayan olgularda perkütan endovasküler tedavi yararlı olabilir.

🔖

Cite This Article

ÇİLDAĞ, M. B., KÖSEOĞLU, Ö. F. K., ERTUĞRUL, M. B. (2017). Infrapopliteal Percutan Transluminal Angioplasty of Patients with TASC D Group Diabetic Foot Lesions According to the Transatlantic Inter-Society Consensus II. Haseki Tıp Bülteni, Cilt: 55 - Sayı: 2, 125–130. https://ajindex.com/articles/204843

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Dormandy J, Heeck L, Vig S. Major amputations: clinical paterns and predictors. Semin Vasc Surg 1999;12:154-61
  2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-28
  3. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ; North-West diabetes foot care study. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the UK: the North-West diabetes foot care study. Diabetes Care 2005;28:1869-75
  4. Adam DJ, Bradbury AW. Tasc ii document on the management of peripheral arterial disease. Eur J Vasc Endovasc Surg 2007;33:1-2
  5. Verzini F, De Rango P, Isernia G, Simonte G, Farchioni L, Cao P. Results of the "endovascular treatment first" policy for infrapopliteal disease. J Cardiovasc Surg 2012;53:179-88
  6. Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: Experience with 443 infrapopliteal procedures. Vascular. 2006;14:63-9
  7. Schmidt A, Ulrich M, Winkler B, et al. Angiographic patency and clinical outcome after balloon angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010;76:1047-54 8. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33 (Suppl 1):S1-75
  8. Towne JB. Management of foot lesions in the diabetic patient. In: Rutherford RB, ed.Vascular Surgery. 5th ed. Philadelphia: WB Saunders Company. 2000;p: 1093
  9. Gibbons GW, Freeman D. Vascular evaluation and treatment of the diabetic. Clin Pediatr Med Surg 1987;4:377-81
  10. Faglia E, Clerici G, Clerissi J, et al. When is a technically successful peripheral an effective in preventing above- the ankle amputation in diabetic patients with critical limb ischaemia? Diabetic Medicine 2007;24:823-9
  11. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb iskemia with below the knee drug eluting stents:the PARADISE (Preventing Amputations Using Drug Eluting Stents) trial. J Am Coll Cardiol 2010;55:1580-89
  12. Ferraresi R, Palena LM, Mauri G, et al. Interventional treatment of the below the ankle peripheral artery disease. In: Lanzer P, editor. PanVascular Medicine. 2nd ed. New York: Springer-Verlag; 2015: 3205-26
  13. Conrad MF, Kang J, Cambria RP, et al. Infrapopliteal balloon angiop